And Sucampo Pharma Americas.

The data presented reflect additional analyses of currently disclosed stage 2 and phase 3 scientific trials of lubiprostone in patients with chronic idiopathic constipation and in patients diagnosed with or reporting irritable bowel syndrome with constipation . Related StoriesExpectant mothers encouraged to consume balanced diet to lessen obesity risk in unborn childLoyola gastroenterologist provides ideas to IBS individuals for healthful livingNew capsule form of FMT raises expectations for dealing with C. Difficile infectionOverall, the info analyses demonstrated that, in these trials, lubiprostone accomplished a statistically significant response in sufferers with IBS-C as compared to placebo sufferers in a number of symptomatic endpoints; demonstrated long-term efficacy via an overall improvement in constipation severity for 12 a few months in adult patients regardless of age, race or gender; and achieved a significant response among refractory constipation individuals as compared to placebo.Unlike earlier sequencers, the HeliScope Sequencer does not make use of polymerase chain reaction amplification to multiply a small number of DNA strands for evaluation, a process that may introduce biases into data. Instead, the HeliScope Sequencer sequences the DNA strand itself actually, enabling direct, high-accuracy measurement. In a paper released in Genome Analysis, RIKEN researchers confirm that this direct strategy reduces biases and generates extremely reproducible data from between 5 micrograms to less than 100 nanograms of total RNA. A comparison utilizing a leukemia cell line and a human being cervical cancer cell collection further demonstrates results from the technique are carefully correlated to those from traditional microarray evaluation.